Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,836 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07734337Enrolling by invitation
Reconstruction surgery for upper body soft tissue defects
This trial tests a surgical technique using a skin flap from the back (called a TDAP flap) to repair defects in the upper body, such as after cancer surgery, injury, or scar release. It may help patients who need reconstructive surgery on the breast, shoulder, chest wall, or armpit.
Sohag, Sohag GovernorateAges 5–75 - NCT06591650RecruitingPhase 2
Combination therapy for advanced gallbladder cancer
This trial is testing a combination of four drugs (gemcitabine, cisplatin, nab-paclitaxel, and durvalumab) for people with gallbladder cancer that has spread or cannot be removed by surgery. The goal is to see if this drug combination helps shrink or control the cancer.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06589973Recruiting
Alcohol Withdrawal: Predicting Complications with Lab Tests
This trial looks at how certain lab results and health factors affect outcomes in people going through alcohol withdrawal. It aims to find better ways to predict and manage complications.
Mexico CityAges 18–80 - NCT07295184Recruiting
Rebound pain and confusion after hip surgery
This study looks at a way to reduce confusion after hip surgery. If you are having planned hip surgery and get a nerve block for pain, researchers will check if rebound pain affects your recovery in the hospital.
Konya, KaratayAges 18–80 - NCT06583577Recruiting
Ostomy simulation education for urologic surgery patients
This study tests a hands-on simulation to help you learn about living with an ostomy before your surgery. It aims to make you more confident and prepared for your recovery.
Minneapolis, MinnesotaAges 18 years+ - NCT07509450Recruiting
Fecal transplant study for CAR-T and stem cell transplant patients
This pilot study tests whether giving a fecal microbiota transplant before standard CAR-T therapy (for B-cell lymphoma) or reduced-intensity stem cell transplant (for AML or high-risk MDS) can improve treatment outcomes. It aims to see if restoring gut bacteria helps reduce complications.
Toronto, OntarioAges 18 years+ - NCT06569485RecruitingPhase 2
Trilaciclib plus chemo for new DLBCL patients
This study tests whether adding a drug called trilaciclib to standard chemotherapy can help people with newly diagnosed Diffuse Large B-Cell Lymphoma. It aims to see if this combination keeps blood counts healthier and improves treatment outcomes.
Guangzhou, GuangdongAges 18 years+ - NCT07396181Recruiting
Standardizing embryo transfer conditions for IVF
This study compares different methods for transferring frozen embryos into the uterus during IVF. It aims to find the best technique to improve pregnancy chances.
WarsawAges 18–38 - NCT07277257RecruitingPhase 4
New dry eye treatment for people with Sjögren's syndrome
This study tests a new treatment for dry eye disease caused by Sjögren's syndrome. It may help people who still have dry eye symptoms even when using artificial tears.
Venice, FloridaAges 18 years+ - NCT07396480RecruitingPhase 3
Add-on Venetoclax before stem cell transplant for AML/MDS
This trial tests adding venetoclax to the usual chemotherapy (fludarabine and melphalan) given before a stem cell transplant for older adults with AML or MDS. The goal is to see if the combination helps prevent the disease from coming back after transplant.
Fuzhou, FujianAges 50–75 - NCT07507760RecruitingPhase 2
Oral decitabine plus ivosidenib for older AML patients
This trial tests a combination of two oral drugs (decitabine and ivosidenib) as a first treatment for older or frail adults with AML that has an IDH1 mutation. The goal is to see if this pill-only regimen is safe and effective without needing intensive chemotherapy.
AlbaceteAges 18 years+ - NCT07455214Recruiting
Heart rate variability and breathing trial success in ventilated patients
This study looks at whether heart rate patterns can help predict if a person on a breathing machine is ready to breathe on their own. It may help doctors decide the best time to try removing the breathing tube.
New Taipei CityAges 18–85 - NCT07729891Recruiting
Vital sign monitoring after urological surgery
This study tests a system that constantly watches your vital signs (like heart rate and blood pressure) after urological surgery, to catch problems early. It's for people who are not expected to need the Intensive Care Unit after their operation.
Parma, ParmaAges 18 years+ - NCT06557044Recruiting
Numbing shot for pain after hip replacement
This study tests if a special numbing shot around the hip joint (PENG block) gives better pain relief after hip replacement. It compares this shot plus standard pain medicine to standard medicine alone.
Stuttgart, Baden-WurttembergAges 18 years+ - NCT06575530RecruitingPhase 4
Remimazolam for sedation after non-cardiac surgery
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
Beijing, Beijing MunicipalityAges 18–64 - NCT06547892RecruitingPhase 2
Vasopressin to prevent kidney injury in the ICU
This trial tests if a drug called vasopressin can help prevent acute kidney injury in patients at high risk. It's for adults in the ICU who have a predicted risk score of 5 or higher based on their lab and health data.
São Paulo, São PauloAges 18 years+ - NCT06539208RecruitingPhase 1/Phase 2
Study of YOLT-201 for transthyretin amyloidosis with nerve or heart damage
This trial tests an experimental gene-editing medicine called YOLT-201 for people with a type of amyloidosis that damages nerves or the heart. It aims to see if one or two doses can safely stop the disease from getting worse.
Beijing, Beijing MunicipalityAges 18–80 - NCT06545292Recruiting
Blood monitoring for cancer drugs using a finger prick
This study tests an easier way to measure the amount of cancer medicine in your blood using a simple finger prick instead of a standard blood draw. If you are taking one of the listed oral or IV cancer drugs, you may be able to participate.
Leiden, South HollandAges 18–90 - NCT05994690RecruitingPhase 3
Newly diagnosed pediatric AML trial with extra treatment options
This trial studies different treatment plans for children and teens newly diagnosed with AML (a type of blood cancer). Depending on the child's tumor markers and risk group, they may be offered an extra drug (quizartinib) or a targeted antibody (Mylotarg) to see if it improves outcomes.
Utrecht, UtrechtAges 1 day–18 years - NCT05997693RecruitingPhase 3
One month of blood thinners after heart bypass surgery
This trial tests whether taking just one month of two blood thinners after coronary artery bypass graft (CABG) surgery is safe and as effective as the standard longer course. It focuses on people having their first bypass surgery who receive at least one vein graft from the leg.
Englewood, New JerseyAges 18 years+ - NCT06532591RecruitingPhase 2
Cadonilimab plus chemo before and after lung cancer surgery
This trial tests a new immunotherapy drug (cadonilimab) combined with standard chemotherapy, given before and after surgery for lung cancer that has very low PD-L1. The goal is to see if this combination helps shrink the tumor and prevents it from coming back.
Chengdu, SichuanAges 18–70 - NCT07281885Recruiting
Aromatherapy for nausea after joint replacement
This study tests whether aromatherapy with essential oils can help reduce nausea and vomiting after total joint replacement surgery. Participants will receive a simple aromatherapy treatment alongside their regular care.
Wong Tai Sin, Hong KongAges 18 years+ - NCT06531551Enrolling by invitation
Acupressure for patients receiving brachytherapy
This study tests whether acupressure (gentle finger pressure on specific body points) can help patients who are receiving brachytherapy for gynecological cancer. It may help manage side effects and improve comfort.
Selçuklu, KonyaAges 18–65 - NCT06528743Recruiting
Testing primer shot radiotherapy for lung cancer
This study is testing a new way of giving a very short, high-dose radiation treatment (called 'primer shot' radiotherapy) for people with non-small cell lung cancer. The goal is to see if it’s safe and practical for shrinking the main lung tumor and relieving symptoms.
AmsterdamAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,836 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.